How accurate is the determination of the relative bioavailability of transdermal drug formulations from pharmacodynamic response data?

Pharmaceutica Acta Helvetiae

Volumn 73, Issue 1, 1998, Pages 63-67

  Leopold, Claudia S ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Biological availability; Dose response relationship; Pharmacokinetics; Reaction time

Indexed keywords

BIOAVAILABILITY; CONFERENCE PAPER; DOSE RESPONSE; DRUG FORMULATION; DRUG PENETRATION; DRUG SOLUBILITY; MATHEMATICAL MODEL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OINTMENTS; PHARMACOKINETICS; REPRODUCIBILITY OF RESULTS;

EID: 0032102736     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(98)00012-0     Document Type: Conference Paper

References (10)

1. Addicks W.J., Flynn G., Weiner N., Curl R. A mathematical model to describe drug release from thin topical applications. Int. J. Pharm. 56:1989;243-248.
2. Addicks W., Weiner N., Flynn G., Curl R., Topp E. Topical drug delivery from thin applications: Theoretical predictions and experimental results. Pharm. Res. 7:1990;1048-1054.
3. Cooper E.R., Berner B. Finite dose pharmacokinetics of skin penetration. J. Pharm. Sci. 74:1985;1100-1102.
4. Guy R.H., Hadgraft J. A theoretical description relating skin penetration to the thickness of the applied medicament. Int. J. Pharm. 6:1980;321-332.
5. Leopold C.S., Lippold B.C. Enhancing effects of lipophilic vehicles on skin penetration of methyl nicotinate in vivo. J. Pharm. Sci. 84:1995;195-198.
6. Lippold B.C., Reimann H. Wirkungsbeeinflussung bei Lösungssalben durch Vehikel am Beispiel von Methylnicotinat, Teil II: Beziehung zwischen relativer thermodynamischer Aktivität und Bioverfügbarkeit: Penetrationsbeschleunigung und Entleerungseffekt. Acta Pharm. Technol. 35:1989;136-142.
7. Lippold B.C., Teubner A. Biopharmazeutische Qualität von Arzneiformen, insbesondere für lokale Anwendung, abgeleitet aus Wirkungsmessungen. Pharm. Ind. 43:1981;71-73.
8. Walker M., Chambers L.A., Hollingsbee D.A., Hadgraft J. Significance of vehicle thickness to skin penetration of halcinonide. Int. J. Pharm. 70:1991;167-172.
9. Zatz J.L. Influence of depletion on percutaneous absorption characteristics. J. Soc. Cosmet. Chem. 36:1985;237-249.
10. Zatz, J.L., 1985b. Percutaneous absorption: Computer simulation using multicompartmented membrane models. In: Bronaugh, R.L., Maibach, H.I. (Eds.), Percutaneous Absorption. Marcel Dekker, New York, pp. 165-181.